Holen Sie sich die Stockscreener-App
7.00
3.18%
-0.23
Handel nachbörslich:
7.00
Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten
What institutional flow reveals about Aura Biosciences Inc.2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Market reaction to Aura Biosciences Inc.’s recent newsJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
Can a trend reversal in Aura Biosciences Inc. lead to recoveryJuly 2025 Highlights & Expert Approved Momentum Ideas - Newser
Aura Biosciences Advances Clinical Trials and Strengthens Finances - TipRanks
Certain Warrants of Aura Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 14-AUG-2025. - MarketScreener
Aura Biosciences Inc: Promising Clinical Developments and Strong Financial Position Support Buy Rating - TipRanks
Aura Biosciences Inc’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating - TipRanks
Positive Outlook on Aura Biosciences: Strategic Developments and Promising Trials Drive Buy Rating - TipRanks
Aura Biosciences: A Strategic Play in High-Unmet-Need Ocular and Urologic Oncology - AInvest
Order flow analysis tools used on Aura Biosciences Inc.July 2025 Movers & Safe Capital Growth Tips - Newser
What MACD and RSI say about Aura Biosciences Inc.2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Aura Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Is Aura Biosciences Inc. forming a reversal patternEarnings Recap Report & Fast Gaining Stock Reports - Newser
Aura Biosciences Q2 revenue down 36%, cash to fund ops into H1 2027. - AInvest
Aura Biosciences Reports Q2 Results and $75M Financing - TipRanks
Aura Biosciences : Corporate Presentation August 2025 - MarketScreener
Aura Biosciences Posts Q2 Cash Surge - The Motley Fool
Aura Biosciences Posts Q2 Cash Surge - Nasdaq
Aura's Vision-Preserving Cancer Therapy Gains Momentum with $75M Boost, Trial Progress - Stock Titan
Aura Biosciences Inc. Trading Near Value Zone — Recovery AheadRisk Controlled Picks With Real Returns Outlined - 선데이타임즈
Regression analysis insights on Aura Biosciences Inc. performancePortfolio Building Plan and Summary Guide - Newser
What makes Aura Biosciences Inc. stock price move sharplyPredictive Model for Intraday Swing Forecast - Newser
Combining price and volume data for Aura Biosciences Inc.Portfolio Allocation Strategy for Stability - Newser
Aura Biosciences Inc.’s volatility index tracking explainedMarket Liquidity and Price Flow Analysis - Newser
Key resistance and support levels for Aura Biosciences Inc.Weekly High Conviction Trade Setup Analysis - Newser
Traders Watching For Reversal Pattern in Aura Biosciences Inc.Real-Time Market Sentiment Tracking Gains Momentum - beatles.ru
Can Aura Biosciences Inc. rally from current levelsBuy Signal System Based on Price Action - Newser
Analyzing drawdowns of Aura Biosciences Inc. with statistical toolsFree Access to Real-Time Trade Insights - Newser
Understanding Aura Biosciences Inc.’s price movementSmart Chart Forecasting with AI Algorithms - Newser
Aura Biosciences (AURA) Expected to Announce Quarterly Earnings on Thursday - Defense World
Aura Biosciences Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Why Aura Biosciences Inc. stock attracts strong analyst attentionSmart Trend Analysis With Buy Point Cues - Newser
Aura Biosciences shares fall 1.78% intraday as Wall Street recovers from Friday's selloff. - AInvest
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):